KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Cash from Operations (QoQ) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -26.62%
Dec 31, 2025 -25.71%
Sep 30, 2025 36.31%
Jun 30, 2025 215.17%
Mar 31, 2025 -76.80%
Dec 31, 2024 29.39%
Sep 30, 2024 139.85%
Jun 30, 2024 -43.79%
Mar 31, 2024 -15.00%
Dec 31, 2023 -37.25%
Sep 30, 2023 19.86%
Jun 30, 2023 50.70%
Mar 31, 2023 -43.55%
Dec 31, 2022 -2.29%
Sep 30, 2022 51.89%
Jun 30, 2022 1.98%
Mar 31, 2022 -3.29%
Dec 31, 2021 -36.04%
Sep 30, 2021 62.27%
Jun 30, 2021 0.27%
Mar 31, 2021 0.47%
Dec 31, 2020 -16.74%
Sep 30, 2020 88.73%
Jun 30, 2020 -19.03%
Mar 31, 2020 16.49%
Dec 31, 2019 -28.10%
Sep 30, 2019 83.89%
Jun 30, 2019 -17.90%
Mar 31, 2019 -11.06%
Dec 31, 2018 -25.02%
Sep 30, 2018 57.85%
Jun 30, 2018 8.36%
Mar 31, 2018 2.36%
Dec 31, 2017 18,357.14%
Sep 30, 2017 7.69%
Jun 30, 2017 -99.38%
Mar 31, 2017 36.40%
Dec 31, 2016 5.98%
Sep 30, 2016 -24.19%
Jun 30, 2016 -9.87%
Mar 31, 2016 8.41%
Dec 31, 2015 -8.91%
Sep 30, 2015 17.63%
Jun 30, 2015 15.58%
Mar 31, 2015 374.22%
Dec 31, 2014 -132.36%
Sep 30, 2014 4.02%
Jun 30, 2014 175.16%
Mar 31, 2014 -49.88%
Dec 31, 2013 -30.76%
Sep 30, 2013 -11.73%
Jun 30, 2013 71.61%
Mar 31, 2013 26.14%
Dec 31, 2012 -58.16%
Sep 30, 2012 44.07%
Jun 30, 2012 -2.07%